Cargando…

Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism

Detalles Bibliográficos
Autores principales: Brix, Thomas H, Hegedüs, Laszlo, Hallas, Jesper, Lund, Lars C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906640/
https://www.ncbi.nlm.nih.gov/pubmed/33617779
http://dx.doi.org/10.1016/S2213-8587(21)00028-0
_version_ 1783655332302553088
author Brix, Thomas H
Hegedüs, Laszlo
Hallas, Jesper
Lund, Lars C
author_facet Brix, Thomas H
Hegedüs, Laszlo
Hallas, Jesper
Lund, Lars C
author_sort Brix, Thomas H
collection PubMed
description
format Online
Article
Text
id pubmed-7906640
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79066402021-02-26 Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism Brix, Thomas H Hegedüs, Laszlo Hallas, Jesper Lund, Lars C Lancet Diabetes Endocrinol Correspondence Elsevier Ltd. 2021-04 2021-02-19 /pmc/articles/PMC7906640/ /pubmed/33617779 http://dx.doi.org/10.1016/S2213-8587(21)00028-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Brix, Thomas H
Hegedüs, Laszlo
Hallas, Jesper
Lund, Lars C
Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
title Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
title_full Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
title_fullStr Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
title_full_unstemmed Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
title_short Risk and course of SARS-CoV-2 infection in patients treated for hypothyroidism and hyperthyroidism
title_sort risk and course of sars-cov-2 infection in patients treated for hypothyroidism and hyperthyroidism
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906640/
https://www.ncbi.nlm.nih.gov/pubmed/33617779
http://dx.doi.org/10.1016/S2213-8587(21)00028-0
work_keys_str_mv AT brixthomash riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism
AT hegeduslaszlo riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism
AT hallasjesper riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism
AT lundlarsc riskandcourseofsarscov2infectioninpatientstreatedforhypothyroidismandhyperthyroidism